Ajanta Pharma USA Inc 2026-07-01 Health serious FDA
Health · FDA · Recall #FDA-D-0611-2026
Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma… Recall
Issued July 1, 2026 · Ajanta Pharma USA Inc
In July 2026, Ajanta Pharma USA Inc recalled the Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma…, a serious health recall reported by the FDA.
Compiled by Dana Whitfield, RecallCheckr
What this means for you
CGMP Deviations
What you should do
- 1 Stop using Fenofibrate Capsules, USP 200 mg, Rx only, 100 Capsules, Manufactured by: Ajanta Pharma… right away.
- 2 Set it aside where it won't be used by mistake.
- 3 Contact Ajanta Pharma USA Inc to arrange your voluntary. See the official notice below for contact details.
- 4 Keep the product until your remedy is fully processed. You may need it.
Official remedy (Voluntary):
Recall details
- Brand
- Ajanta Pharma USA Inc
- Category
- Health
- Recall date
- July 1, 2026
- Units affected
- Not reported
- Sold at
- U.S. Nationwide
- Recall number
- FDA-D-0611-2026
- Made in
- United States
- Issuing agency
- FDA
In context
- Ajanta Pharma USA Inc has 1 recall in our database.
- We're tracking 3,673 Health recalls in our database.
- This is the 453rd Health recall we've logged in 2026.